Globus Medical (GMED) EV to CFO (2012 - 2026)

Globus Medical (GMED) has reported EV to CFO for 15 consecutive years, with 47.74 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to CFO fell 51.98% year-over-year to 47.74; the trailing twelve-month figure through Jun 2026 stood at 11.0 (down 4.93% YoY), and the FY2025 full-year result was 14.93, down 25.85% from the prior year.
• EV to CFO fell to 47.74 in Q2 2026 per GMED's latest filing, from 54.68 in the prior quarter.
• Across five years, EV to CFO topped out at 168.36 in Q3 2022 and bottomed at 29.13 in Q3 2025.
• Historically, EV to CFO has averaged 96.37 across 5 years, with a median of 98.28 in 2023.
• The sharpest annual moves came in 2022 and 2024: EV to CFO surged 80.12% in 2022, then slumped 65.56% in 2024.
• Over 5 years, EV to CFO stood at 109.47 in 2022, then tumbled by 41.56% to 63.97 in 2023, then fell by 22.07% to 49.85 in 2024, then retreated by 9.21% to 45.26 in 2025, then increased by 5.47% to 47.74 in 2026.
• According to Business Quant data, EV to CFO over the past three periods registered 47.74, 54.68, and 45.26 for Q2 2026, Q1 2026, and Q4 2025 respectively.